Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches

por Mukherjee, Amrita, Verma, Ayushi, Bihani, Surbhi, Burli, Ananya, Mantri, Krishi, Srivastava, Sanjeeva
Publicado 2021

Humoral Immune Response Profile of COVID-19 Reveals Severity and Variant-Specific Epitopes: Lessons from SARS-CoV-2 Peptide Microarray

por Acharjee, Arup, Ray, Arka, Salkar, Akanksha, Bihani, Surbhi, Tuckley, Chaitanya, Shastri, Jayanthi, Agrawal, Sachee, Duttagupta, Siddhartha, Srivastava, Sanjeeva
Publicado 2023

Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential

por Suvarna, Kruthi, Biswas, Deeptarup, Pai, Medha Gayathri J., Acharjee, Arup, Bankar, Renuka, Palanivel, Viswanthram, Salkar, Akanksha, Verma, Ayushi, Mukherjee, Amrita, Choudhury, Manisha, Ghantasala, Saicharan, Ghosh, Susmita, Singh, Avinash, Banerjee, Arghya, Badaya, Apoorva, Bihani, Surbhi, Loya, Gaurish, Mantri, Krishi, Burli, Ananya, Roy, Jyotirmoy, Srivastava, Alisha, Agrawal, Sachee, Shrivastav, Om, Shastri, Jayanthi, Srivastava, Sanjeeva
Publicado 2021